[Isolated fear of frogs and toads--a case of bufono-ranophobia]. 2012

Horst J Koch, and Chr Gehring
Klinik für Psychiatrie und Psychotherapie, HELIOS Klinikum Aue. horst.koch@helios-kliniken.de

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010698 Phobic Disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable. Claustrophobia,Neuroses, Phobic,Phobia, School,Phobias,Phobic Neuroses,Scolionophobia,Disorder, Phobic,Phobia,Phobic Disorder,School Phobia
D011613 Psychotherapy A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication. Psychotherapies
D011898 Ranidae The family of true frogs of the order Anura. The family occurs worldwide except in Antarctica. Frogs, True,Rana,Frog, True,True Frog,True Frogs
D002025 Bufonidae The family of true toads belonging to the order Anura. The genera include Bufo, Ansonia, Nectophrynoides, and Atelopus. Bufo,Toads, True,Bufos,Toad, True,True Toad,True Toads
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003987 Dibenzothiazepines
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069348 Quetiapine Fumarate A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER. 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol,Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt),ICI 204,636,ICI 204636,ICI-204636,Quetiapine,Seroquel,ICI204636

Related Publications

Horst J Koch, and Chr Gehring
August 1991, Zentralblatt fur Bakteriologie : international journal of medical microbiology,
Horst J Koch, and Chr Gehring
March 1994, Scientific American,
Horst J Koch, and Chr Gehring
December 1962, The Quarterly review of biology,
Horst J Koch, and Chr Gehring
November 1950, The American journal of physiology,
Horst J Koch, and Chr Gehring
November 1998, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Horst J Koch, and Chr Gehring
April 2009, Heredity,
Horst J Koch, and Chr Gehring
January 2003, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
Horst J Koch, and Chr Gehring
November 1950, Klinische Wochenschrift,
Horst J Koch, and Chr Gehring
January 1952, Hippokrates,
Horst J Koch, and Chr Gehring
August 1964, Endocrinology,
Copied contents to your clipboard!